Evidence map›Paper›PMID 33826889›Full record

ArticleCell reports2021

MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation.

Vijay Swahari, Ayumi Nakamura, Emilie Hollville, Hume Stroud, Jeremy M Simon, Travis S Ptacek, Matthew V Beck, Cornelius Flowers, Jiami Guo, Charlotte Plestant and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. MicroRNAs and synaptic dysfunction in Parkinson's disease.Molecular therapy. Nucleic acids · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Vijay SwahariNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: swahari@email.unc.edu.
Ayumi NakamuraNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA; Neurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA.
Emilie HollvilleNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Hume StroudDepartment of Neurobiology, Harvard University, Boston, MA, USA.
Jeremy M SimonNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA.
Travis S PtacekNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA.
Matthew V BeckNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Cornelius FlowersNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Jiami GuoNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Charlotte PlestantNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Jie LiangDepartment of Immunology, Duke University, Durham, NC, USA.
C Lisa KurtzDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA.
Matt KankeDepartment of Biomedical Sciences, Cornell University, Ithaca, NY, USA.
Scott M HammondDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.
You-Wen HeDepartment of Immunology, Duke University, Durham, NC, USA.
E S AntonNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA; Neurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA; Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.
Praveen SethupathyDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA; Department of Biomedical Sciences, Cornell University, Ithaca, NY, USA.
Sheryl S MoyDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA.
Michael E GreenbergDepartment of Neurobiology, Harvard University, Boston, MA, USA.
Mohanish DeshmukhNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA; Neurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA; Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA. Electronic address: mohanish@med.unc.edu.
University of North Carolina at Chapel Hill · USCornell University · USDuke University · USHarvard University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
The UNC Chapel Hill Superfund Research Program (UNC-SRP)P42ES031007 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Gray · 2020 to 2026
$22.2M
UNC Neuroscience Center Research Cores: MicroscopyP30NS045892 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2003 to 2022
$11.5M
Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GABRIEL S DICHTER · 2020 to 2026
$9.7M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LINNAN, LAURA A · 2010 to 2020
$9.7M
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 2013 to 2019
$8.0M
DEFINING MECHANISMS OF PROGENITOR BALANCE AND NEURONAL CONNECTIVITYR35NS116859 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EVA S ANTON · 2020 to 2026
$4.1M
Essential Function of miR-29 in the Mature BrainR01AG055304 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2017 to 2021
$2.6M
Role of Radial Glial Tiling in the Formation and Malformation of the Cerebral CortexR01HD098657 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANTON, EVA S · 2019 to 2023
$2.5M
Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to CancerR35GM118331 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2016 to 2020
$2.2M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA016086NCI NIH HHS U54 CA156733NIA NIH HHS R01 AG055304NICHD NIH HHS P50 HD103573NICHD NIH HHS R01 HD098657NICHD NIH HHS U54 HD079124NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES031007NIGMS NIH HHS R35 GM118331NINDS NIH HHS P30 NS045892NINDS NIH HHS R35 NS116859
6 · The paper itself

Abstract

Although embryonic brain development and neurodegeneration have received considerable attention, the events that govern postnatal brain maturation are less understood. Here, we identify the miR-29 family to be strikingly induced during the late stages of brain maturation. Brain maturation is associated with a transient, postnatal period of de novo non-CG (CH) DNA methylation mediated by DNMT3A. We examine whether an important function of miR-29 during brain maturation is to restrict the period of CH methylation via its targeting of Dnmt3a. Deletion of miR-29 in the brain, or knockin mutations preventing miR-29 to specifically target Dnmt3a, result in increased DNMT3A expression, higher CH methylation, and repression of genes associated with neuronal activity and neuropsychiatric disorders. These mouse models also develop neurological deficits and premature lethality. Our results identify an essential role for miR-29 in restricting CH methylation in the brain and illustrate the importance of CH methylation regulation for normal brain maturation.

Indexed as

3' Untranslated RegionsAnimalsAnimals, NewbornBase SequenceBehavior, AnimalBrainDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDown-RegulationGene Expression Regulation, DevelopmentalMiceMice, Inbred C57BLMicroRNAsNeurodevelopmental DisordersNeuronsSeizures3' Untranslated RegionsDNA (Cytosine-5-)-MethyltransferasesMicroRNAsMIRN29 microRNA, mouseautismCH methylationDNMT3AepilepsyMeCP2miR-29miRNAneurodevelopmental disordersnon-CG methylationseizures

Identifiers

PMID33826889
PMCPMC8103628
OpenAlexW3151248576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.